Your browser doesn't support javascript.
loading
Olfactory receptor 5B21 drives breast cancer metastasis.
Li, Mao; Schweiger, Markus W; Ryan, Daniel J; Nakano, Ichiro; Carvalho, Litia A; Tannous, Bakhos A.
Afiliação
  • Li M; Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
  • Schweiger MW; Experimental Therapeutics and Molecular Imaging Laboratory, Department of Neurology, Neuro-Oncology Division, Massachusetts General Hospital, 149 13th Street, Charlestown, Boston, MA 02129, USA.
  • Ryan DJ; Neuroscience Program, Harvard Medical School, Boston, MA 02129, USA.
  • Nakano I; Experimental Therapeutics and Molecular Imaging Laboratory, Department of Neurology, Neuro-Oncology Division, Massachusetts General Hospital, 149 13th Street, Charlestown, Boston, MA 02129, USA.
  • Carvalho LA; Neuroscience Program, Harvard Medical School, Boston, MA 02129, USA.
  • Tannous BA; Department of Neurosurgery, Cancer Center Amsterdam, Brain Tumor Center Amsterdam, Amsterdam UMC, Vrije Universiteit, 1081 HV Amsterdam, the Netherlands.
iScience ; 24(12): 103519, 2021 Dec 17.
Article em En | MEDLINE | ID: mdl-34917897
ABSTRACT
Olfactory receptors (ORs), responsible for the sense of smell, play an essential role in various physiological processes outside the nasal epithelium, including cancer. In breast cancer, however, the expression and function of ORs remain understudied. We examined the significance of OR transcript abundance in primary and metastatic breast cancer to the brain, bone, and lung. Although 20 OR transcripts were differentially expressed in distant metastases, OR5B21 displayed an increased transcript abundance in all three metastatic sites compared with the primary tumor. Knockdown of OR5B21 significantly decreased the invasion and migration of breast cancer cells as well as metastasis to different organs especially the brain, whereas increasing of OR5B21 transcript abundance had the opposite effect. Mechanistically, OR5B21 expression was associated with epithelial to mesenchymal transition through the STAT3/NF-κB/CEBPß signaling axis. We propose OR5B21 (and potentially other ORs) as a novel oncogene contributing to breast cancer metastasis and a potential target for adjuvant therapy.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article